You are required to be logged in to access the full website
Click here if you have forgotten your username or password
27 May 2022 - - US-based clinical-stage biopharmaceutical company Xencor, Inc. (NASDAQ: XNCR) has reported initial dose-escalation data from the Phase 1 study evaluating XmAb104, a PD-1 x ICOS bispecific antibody, in patients with advanced solid tumo...
27 May 2022 - - US-based clinical-stage biopharmaceutical company Tvardi Therapeutics, Inc's lead product, TTI-101, has been granted Orphan Drug Designation by the US Food and Drug Administration for the treatment of idiopathic pulmonary fi...
27 May 2022 - - US-based clinical-stage biotechnology company Scioto Biosciences, Inc has released top-line results of its Phase Ib trial of lead asset, SB-121, based on its novel microbiome delivery platform, Activated Bacterial Therapeutics, w...
27 May 2022 - - The US Food and Drug Administration has accepted for filing and granted Priority Review of US-based clinical-stage biopharmaceutical company Reata Pharmaceuticals, Inc's (NASDAQ: RETA) New Drug Application for omaveloxolone ...
27 May 2022 - - The US Food and Drug Administration has granted Fast Track designation to US-based pharmaceutical company Pfizer Inc's (NYSE: PFE) investigational combination therapy for the treatment of non-alcoholic steatohepatitis with l...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe